Regulation of NFATc1 in Osteoclast Differentiation

Overview

Journal J Bone Metab

Date 2014 Dec 10

PMID 25489571

Citations 243

Authors

Jung Ha Kim

Nacksung Kim

Affiliations

Soon will be listed here.

Abstract

Osteoclasts are unique cells that degrade the bone matrix. These large multinucleated cells differentiate from the monocyte/macrophage lineage upon stimulation by two essential cytokines, macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappa B (NF-κB) ligand (RANKL). Activation of transcription factors such as microphthalmia transcription factor (MITF), c-Fos, NF-κB, and nuclear factor-activated T cells c1 (NFATc1) is required for sufficient osteoclast differentiation. In particular, NFATc1 plays the role of a master transcription regulator of osteoclast differentiation. To date, several mechanisms, including transcription, methylation, ubiquitination, acetylation, and non-coding RNAs, have been shown to regulate expression and activation of NFATc1. In this review, we have summarized the various mechanisms that control NFATc1 regulation during osteoclast differentiation.

Citing Articles

Arcyriaflavin A Alleviates Osteoporosis by Suppressing RANKL-Induced Osteoclastogenesis.

Zhu M, Xu M, Bertheloot D, Brom V, Sieberath A, Salber J Int J Mol Sci. 2025; 26(5).

PMID: 40076762 PMC: 11899857. DOI: 10.3390/ijms26052141.

Network Pharmacology Analysis and Biological Validation Systemically Identified the Active Ingredients and Molecular Targets of Kudzu Root on Osteoporosis.

Liu Z, Zhang B, Kwok K, Dong X, Wong K Int J Mol Sci. 2025; 26(3).

PMID: 39940967 PMC: 11818621. DOI: 10.3390/ijms26031202.

Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy.

Luo C, Dai Z, He W, He Y, Yang P, Huang M Front Nutr. 2025; 12:1508695.

PMID: 39917743 PMC: 11798809. DOI: 10.3389/fnut.2025.1508695.

A Mechanically Stimulated Co-culture in 3-Dimensional Composite Scaffolds Promotes Osteogenic and Anti-osteoclastogenic Activity and M2 Macrophage Polarization.

Kontogianni G, Loukelis K, Bonatti A, Batoni E, De Maria C, Vozzi G Biomater Res. 2025; 29:0135.

PMID: 39911306 PMC: 11794764. DOI: 10.34133/bmr.0135.

Targeting TRPC channels for control of arthritis-induced bone erosion.

Ray S, McCall J, Tian J, Jeon J, Douglas A, Tyler K Sci Adv. 2025; 11(3):eabm9843.

PMID: 39813349 PMC: 11734723. DOI: 10.1126/sciadv.abm9843.

References

Jang H, Shin J, Park D, Hong J, Yoon K, Ko R . Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation. J Biol Chem. 2011; 286(45):39043-50. PMC: 3234729. DOI: 10.1074/jbc.M111.256768. View

Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K . NFAT and Osterix cooperatively regulate bone formation. Nat Med. 2005; 11(8):880-5. DOI: 10.1038/nm1270. View

Yasui T, Hirose J, Aburatani H, Tanaka S . Epigenetic regulation of osteoclast differentiation. Ann N Y Acad Sci. 2011; 1240:7-13. DOI: 10.1111/j.1749-6632.2011.06245.x. View

Hogan P, Chen L, Nardone J, Rao A . Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17(18):2205-32. DOI: 10.1101/gad.1102703. View

Lee Y, Kim H, Park C, Kim Y, Lee H, Kim J . MicroRNA-124 regulates osteoclast differentiation. Bone. 2013; 56(2):383-9. DOI: 10.1016/j.bone.2013.07.007. View

Kim J, Kim K, Youn B, Jin H, Kim J, Moon J . RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation. Biochem J. 2011; 436(2):253-62. DOI: 10.1042/BJ20110062. View

Wang Z, Ovitt C, Grigoriadis A, Ruther U, Wagner E . Bone and haematopoietic defects in mice lacking c-fos. Nature. 1992; 360(6406):741-5. DOI: 10.1038/360741a0. View

Aliprantis A, Ueki Y, Sulyanto R, Park A, Sigrist K, Sharma S . NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest. 2008; 118(11):3775-89. PMC: 2564610. DOI: 10.1172/JCI35711. View

Teitelbaum S . Bone resorption by osteoclasts. Science. 2000; 289(5484):1504-8. DOI: 10.1126/science.289.5484.1504. View

10.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H . Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3(6):889-901. DOI: 10.1016/s1534-5807(02)00369-6. View

11.

Matsuo K, Galson D, Zhao C, Peng L, Laplace C, Wang K . Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 2004; 279(25):26475-80. DOI: 10.1074/jbc.M313973200. View

12.

Chen K, Rajewsky N . The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007; 8(2):93-103. DOI: 10.1038/nrg1990. View

13.

Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R . Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med. 1997; 3(11):1285-9. DOI: 10.1038/nm1197-1285. View

14.

Kim K, Kim J, Lee J, Jin H, Kook H, Kim K . MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood. 2006; 109(8):3253-9. DOI: 10.1182/blood-2006-09-048249. View

15.

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

16.

Kim K, Kim J, Lee J, Jin H, Lee S, Fisher D . Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem. 2005; 280(42):35209-16. DOI: 10.1074/jbc.M505815200. View

17.

Zhao B, Takami M, Yamada A, Wang X, Koga T, Hu X . Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med. 2009; 15(9):1066-71. PMC: 2755267. DOI: 10.1038/nm.2007. View

18.

Ruocco M, Maeda S, Park J, Lawrence T, Hsu L, Cao Y . I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J Exp Med. 2005; 201(10):1677-87. PMC: 2212920. DOI: 10.1084/jem.20042081. View

19.

Yasui T, Hirose J, Tsutsumi S, Nakamura K, Aburatani H, Tanaka S . Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J Bone Miner Res. 2011; 26(11):2665-71. DOI: 10.1002/jbmr.464. View

20.

Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S . Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem. 2004; 279(44):45969-79. DOI: 10.1074/jbc.M408795200. View